Valuation (69%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -9.10 | 10.36 |
PEG Ratio (TTM) | 0.20 | -0.39 |
P/S Ratio (TTM) | 0.98 | 2.81 |
P/B Ratio (TTM) | 1.43 | 2.68 |
P/FCF Ratio (TTM) | 14.41 | 13.36 |
Price to 5YR AVG Earnings Ratio | 10.12 | 9.68 |
Price to 5YR AVG FCF Ratio | 9.76 | 9.09 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | -10.70% | 1.45% |
ROE (TTM) | -14.60% | 10.69% |
Net Profit Margin (TTM) | -10.91% | -123.00% |
ROIC 5YR AVG | 22.78% | 21.25% |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -172.40% | 38.40% | -14.29% |
Revenue | -8.75% | 22.82% | 8.49% |
Net Income | -170.65% | 38.37% | -14.42% |
Cash Flow | -3.21% | 26.84% | 4.53% |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.55 | 1.83 |
Quick Ratio (TTM) | 0.52 | 0.89 |
D/E Ratio (TTM) | 0.05 | 1.53 |
Interest Coverage (TTM) | 5.09 | 16.69 |
Piotroski F-Score | 4 | 7 |
Altman Z-Score | 3.42 | 2.76 |
LTL to 5YR AVG FCF | N/A | 5.03 |
Shares Outstanding Growth 5YR AVG | -0.38% | -1.90% |